Inertia to Integrate Orthobiologics into Orthopaedic Practise: Are We Asking the Right Question?

One of the most ironic realities of orthopedic regenerative
medicine practice is that, before being able to consider any
treatment methods involving regenerative medicine, we frequently ask for high-quality evidence [1]. If we look closer, we must only consider only procedures with level 1 evidence from either randomized controlled trials (RCTs) or reviews of similar RCTs favoring their use in our orthopedic practice. However, one must realize that for a treatment method to reach such a high level of evidence, it needs to be embraced in the first hand considering the ingenuity and potential behind its usage from the preclinical and in-vitro studies backing their use. Moreover, these procedures need
to travel a long way until it acquires a high-level research funding to generate sufficient high-quality evidence to grab its place in routine practice.